Status:

TERMINATED

Use of the Ulcerative Colitis Diet for Induction of Remission

Lead Sponsor:

Prof. Arie Levine

Conditions:

Ulcerative Colitis (UC)

Eligibility:

All Genders

5-18 years

Phase:

NA

Brief Summary

The goal of the study is to evaluate the use of Ulcerative Colitis Diet for Induction of Remission. The investigators have postulated that we developed could be beneficial for patients with Ulcerative...

Detailed Description

Background: Recent research has shown that dietary components may lead to impaired intestinal innate immunity due to alterations in the microbiome, mucous layer, intestinal permeability or change in ...

Eligibility Criteria

Inclusion

  • Informed consent
  • Established diagnosis of UC disease.
  • Age: 5 - 18 years ( inclusive)
  • Mild to moderate active disease, 10 ≤ PUCAI ≤45.
  • Stable medication (IMM/ 5ASA) use for the past 6 weeks.
  • For patients who received antibiotic treatment: age 10-18 (inclusive).

Exclusion

  • Any proven infection such as positive stool culture, parasite or C.difficile.
  • Use of Antibiotics
  • Use of steroids in the previous two weeks only
  • Patients that are refractory to full dose steroids ( 1 mg/kg/day)
  • Past acute severe UC.
  • Current Extra intestinal manifestation of UC.
  • Pregnancy.
  • A subset of patients who are on steroids and relapse during steroids treatment ≤0.5 mg/kg with mild to moderate disease activity will act as a second subset for this exploratory study.
  • \-

Key Trial Info

Start Date :

October 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2016

Estimated Enrollment :

9 Patients enrolled

Trial Details

Trial ID

NCT02217722

Start Date

October 1 2014

End Date

February 1 2016

Last Update

August 11 2016

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The E.Wolfson Medical Center

Holon, Israel, 58100